Silence Therapeutics Plc (SLN) - Financial and Strategic SWOT Analysis Review

  • ID: 4278595
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a research and development company that develops and delivers RNA interference therapeutics for the treatment of serious diseases. The company's pipeline products include Atu027 and Atu111. Its Atu027 is developed for the treatment of pancreatic, head and neck cancer. Silence Therapeutics offers Atu111 for lung indications. The company also develops other products which include PF-655 for diabetic macular edema and wet age related macular degeneration; and QPI 1002 for kidney transplantation and acute kidney injury. It has collaboration with pharmaceutical, biotechnology companies and academic research institutions. The company has presence in Berlin, Germany. Silence Therapeutics is headquartered in London, the UK.

Silence Therapeutics Plc Key Recent Developments

Mar 06, 2018: Silence Therapeutics: Preliminary results for the year ended 31 December 2017
Jan 22, 2018: Silence Therapeutics: Key European patent granted
Jan 08, 2018: Silence Therapeutics: Post year end business update
Nov 20, 2017: Silence Therapeutics: Update on litigation matters
Nov 03, 2017: Silence Therapeutics: Update on litigation matters

This comprehensive SWOT profile of Silence Therapeutics Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Silence Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • Silence Therapeutics Plc - Key Information
  • Silence Therapeutics Plc - Overview
  • Silence Therapeutics Plc - Key Employees
  • Silence Therapeutics Plc - Key Employee Biographies
  • Silence Therapeutics Plc - Key Operational Heads
  • Silence Therapeutics Plc - Major Products and Services
  • Silence Therapeutics Plc - History
  • Silence Therapeutics Plc - Company Statement
  • Silence Therapeutics Plc - Locations And Subsidiaries
  • Silence Therapeutics Plc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Silence Therapeutics Plc - Business Description
  • Silence Therapeutics Plc - Corporate Strategy
  • Silence Therapeutics Plc - SWOT Analysis
  • SWOT Analysis - Overview
  • Silence Therapeutics Plc - Strengths
  • Silence Therapeutics Plc - Weaknesses
  • Silence Therapeutics Plc - Opportunities
  • Silence Therapeutics Plc - Threats
  • Silence Therapeutics Plc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Silence Therapeutics Plc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Silence Therapeutics Plc, Key Information
  • Silence Therapeutics Plc, Key Ratios
  • Silence Therapeutics Plc, Share Data
  • Silence Therapeutics Plc, Major Products and Services
  • Silence Therapeutics Plc, History
  • Silence Therapeutics Plc, Key Employees
  • Silence Therapeutics Plc, Key Employee Biographies
  • Silence Therapeutics Plc, Key Operational Heads
  • Silence Therapeutics Plc, Other Locations
  • Silence Therapeutics Plc, Subsidiaries
  • Silence Therapeutics Plc, Key Manufacturing facilities
  • Silence Therapeutics Plc, Key Competitors
  • Silence Therapeutics Plc, SWOT Analysis
  • Silence Therapeutics Plc, Ratios based on current share price
  • Silence Therapeutics Plc, Annual Ratios
  • Silence Therapeutics Plc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Silence Therapeutics Plc, Performance Chart
  • Silence Therapeutics Plc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll